Your browser doesn't support javascript.
loading
Evaluation of the Muscle Strength of the Tongue with the Tongue Digital Spoon (TDS) in Patients with Obstructive Sleep Apnea.
Rodríguez-Alcalá, Laura; Benjumea, Felipe; Casado-Morente, Juan Carlos; Baptista, Peter M; O'Connor-Reina, Carlos; Plaza, Guillermo.
Afiliação
  • Rodríguez-Alcalá L; Otorhinolaryngology Department, Hospital Quironsalud Marbella, 29603 Málaga, Spain.
  • Benjumea F; Otorhinolaryngology Department, Hospital Quironsalud Marbella, 29603 Málaga, Spain.
  • Casado-Morente JC; Otorhinolaryngology Department, Hospital Quironsalud Marbella, 29603 Málaga, Spain.
  • Baptista PM; Otorhinolaryngology Department, Clínica Universidad de Navarra, 31007 Pamplona, Spain.
  • O'Connor-Reina C; Otorhinolaryngology Department, Hospital Quironsalud Marbella, 29603 Málaga, Spain.
  • Plaza G; Otorhinolaryngology Department, Hospital Universitario de Fuenlabrada, Universidad Rey Juan Carlos, 28042 Madrid, Spain.
Life (Basel) ; 12(11)2022 Nov 10.
Article em En | MEDLINE | ID: mdl-36362996
ABSTRACT
Myofunctional therapy (MT) is a recent treatment option for obstructive sleep apnea (OSA). The Iowa Oral Performance Instrument (IOPI) is a useful but expensive tool for measuring tongue strength in patients with OSA. We validated the Tongue Digital Spoon (TDS) to monitor tongue hypotonia in patients with OSA. Measurements with the IOPI and TDS were compared in patients with OSA before and after MT for tongue hypotonia. Baseline mean tongue strength measured with the IOPI in patients with moderate and severe OSA were 35.36 ± 9.05 and 33.83 ± 12.05, respectively, and that with the TDS were 168.55 ± 42.8 and 129.61 ± 53.7, respectively. After MT, mean tongue strength significantly improved measured with the IOPI in patients with moderate and severe OSA were 53.85 ± 10.09 and 55.50 ± 9.64 (p = 0.8), and that with the TDS were 402.36 ± 52.92 and 380.28 ± 100.75 (p = 0.01), respectively. The correlation between the IOPI and TDS was high (r = 0.74; p = 0.01 pre-treatment, and r = 0.25; p = 0.05 post-treatment). The TDS is a useful tool for monitoring the efficacy of MT in patients with short-term OSA. Future randomized studies will determine the effectiveness of MT for the treatment of OSA.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article